Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Justin Miller

Gastroenterology Wilmington, NC Medical Doctor

NPI 1134566268 CMS profile 4219578

5115 Oleander Dr Rm 8549, Wilmington, NC 28403

Open in the dashboard

General payments

$6,279

266 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Miller of Wilmington, NC is reported in the CMS Open Payments database as having received $6,279 across 266 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,137 53
2024 General $1,527 54
2023 General $997 53
2022 General $1,386 56
2021 General $496 28
2020 General $124 5
2019 General $611 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Miller
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Justin Miller were reported at $1,137. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Justin Miller Gastroenterology median Middle half National median
2019 $611 $417 $126–$1,100 $163
2020 $124 $224 $74–$624 $114
2021 $496 $352 $106–$1,054 $132
2022 $1,386 $448 $129–$1,270 $149
2023 $997 $533 $150–$1,390 $160
2024 $1,527 $605 $160–$1,606 $164
2025 $1,137 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $2,013 99 payments
  2. Boston Scientific Corporation $400 7 payments
  3. Medtronic, Inc. $337 4 payments
  4. Salix Pharmaceuticals, a division of Bausch Health US, LLC $319 14 payments
  5. Janssen Biotech, Inc. $314 12 payments
  6. Regeneron Healthcare Solutions, Inc. $245 9 payments
  7. Gilead Sciences, Inc. $238 11 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $236 14 payments
  9. CONMED Corporation $203 2 payments
  10. Celgene Corporation $200 13 payments
  11. Other $1,772 81 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,264 265 payments
  2. Education $15 1 payment
Products named General payments · program years 2019–2025
  1. SKYRIZI Immunology $824 31 payments
  2. RINVOQ $509 36 payments
  3. MAVYRET $446 16 payments
  4. SKYRIZI Immunology $261 16 payments
  5. STELARA $242 8 payments
  6. XIFAXAN $238 9 payments
  7. DUPIXENT $229 8 payments
  8. CONMED HEMOSTASIS $203 2 payments
  9. CONMED GENERATORS $203 2 payments
  10. CONMED BILIARY $203 2 payments
  11. Other $3,681 168 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

369

Median for Gastroenterology: 569

Drug cost

$178,046

Median for Gastroenterology: $104,976

Branded share of claims

13.3%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rinvoq Upadacitinib Brand 15 $147,306
Linzess Linaclotide Brand 20 $15,245
Motegrity Prucalopride Succinate Brand 14 $8,016
Sucralfate Generic 26 $2,287
Esomeprazole Magnesium Generic 39 $2,030
Omeprazole Generic 149 $1,819
Pantoprazole Sodium Generic 72 $1,238
Ciprofloxacin Hcl Generic 18 $62
Buspirone Hcl Generic 16 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 80 billing codes

Paid by Medicare

$188,754

Medicare's payments for the services billed

Medicare patients

472

Average age 73

Services billed

4,884

242 women, 230 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 46%
Diabetes 32%
Ischemic heart disease 30%
Chronic kidney disease 22%
Depression 22%
Cancer 19%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 16 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
  • AbbVie, Inc. $195
$195 — —
DUPIXENT
  • GENZYME CORPORATION $117
  • Regeneron Healthcare Solutions, Inc. $54
$171 — —
RINVOQ
  • AbbVie, Inc. $121
$121 15 —
STELARA
  • Janssen Biotech, Inc. $117
$117 — —
TREMFYA
  • Janssen Biotech, Inc. $82
$82 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 16 in the dashboard with a free account

Records

266 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record